Fate Therapeutics, Inc. (FATE)

1.62 +0.11 (+7.28%) USD  |  NASDAQ  |  Feb 24, 16:00
1.63 +0.01 (+0.62%) After-Hours: 07:52
More

Fate Therapeutics Other Receivables (Quarterly)

Other Receivables (Quarterly) Chart

View Other Receivables (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Receivables (Quarterly) Range, Past 5 Years

View Other Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Receivables (Quarterly) Benchmarks

View Other Receivables (Quarterly) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade